Company / Capital Expenditures
NEPHROS INC Capital Expenditures History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$75.0K
FY2024
5-year range
$36.0K / $137.0K
FY2020-FY2024
Trend
-45.3%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures has fluctuated over the past 8 years, ranging from $14,000 in FY2019 to $239,000 in FY2020.
Based on SEC 10-K filings.
$75,000 in FY2024 with a 5-year CAGR of +39.9%.
Declined from $137,000 to $75,000 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +27.7%
- 5-Year CAGR
- +39.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +39.9%, indicating consistent growth.
- In FY2024, capital expenditures decreased 45.3% year-over-year.
- Peak capital expenditures was recorded in FY2020.
- Lowest capital expenditures in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -5.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $75.0K | -45.3% |
| FY2023 | $137.0K | +0.0% |
| FY2022 | $137.0K | +280.6% |
| FY2021 | $36.0K | -84.9% |
| FY2020 | $239.0K | +1607.1% |
| FY2019 | $14.0K | - |
| FY2018 | - | - |
| FY2017 | $45.0K | +0.0% |
| FY2016 | $45.0K | +246.2% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026